| Filed On | Filing |
|---|---|
| 25 Sep 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On September 19, 2017, the Board of Directors of the Company appointed Mr. Stuglik to serve on the Compensation Committee. |
| 11 Jan 2017 |
8-K/A: Other Events
As previously disclosed, under the terms of the License Agreement, Infinity granted to the Company an exclusive worldwide license for the research, development, commercialization, and manufacture of products in oncology indications conta... |
Loading...